NexgenRx Inc.
NEGXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -30.6% | -4.5% | 15.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 74.3% | 81.9% | 79.6% | 85.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22% | 15.2% | 18.2% | 18.9% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 14% | 8.1% | 11.6% | -0.7% |
| EPS Diluted | 0.006 | 0.005 | 0.006 | -0 |
| % Growth | 12% | -16.7% | 1,600% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |